(c) 2024 PillSync.com

ziprasidone 40 MG Oral Capsule

1. INDICATIONS AND USAGE Ziprasidone hydrochloride capsules are indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [ see Warnings and Precautions ( 5.3 )]. Prolongation of the QTc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. In many cases this would lead to the conclusion that other drugs should be tried first. Whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see Warnings and Precautions ( 5.3 )] Schizophrenia Ziprasidone is indicated for the treatment of schizophrenia in adults [see Clinical Studies ( 14.1 )]. Bipolar I Disorder (Acute Mixed or Manic Episodes and Maintenance Treatment as an Adjunct to Lithium or Valproate) Ziprasidone is indicated as monotherapy for the acute treatment of adults with manic or mixed episodes associated with bipolar I disorder [see Clinical Studies ( 14.2 )] . Ziprasidone is indicated as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder in adults [see Clinical Studies ( 14.2 )] . Ziprasidone is an atypical antipsychotic. In choosing among treatments, prescribers should be aware of the capacity of ziprasidone to prolong the QT interval and may consider the use of other drugs first ( 5.3 ) Ziprasidone hydrochloride capsules are indicated as an oral formulation for the: Treatment of schizophrenia. Acute treatment as monotherapy of manic or mixed episodes associated with bipolar I disorder Maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate.

Zydus Pharmaceuticals (USA) Inc.


4 years ago CAPSULE BLUE 238 ziprasidone 40 MG Oral Capsule

CAPSULE BLUE 238

16. HOW SUPPLIED/STORAGE AND HANDLING Ziprasidone hydrochloride capsules, 20 mg are white to slightly pink granular powder filled in size '4' hard gelatin capsules having a dark blue opaque cap printed with '237' in white ink and a white opaque body and are supplied as: NDC 68382-237-14 in bottle of 60 capsules NDC 68382-237-05 in bottle of 500 capsules NDC 68382-237-80 in cartons of 80 capsules (8 x 10 unit-dose) Ziprasidone hydrochloride capsules, 40 mg are white to slightly pink granular powder filled in size '3' hard gelatin capsules having a dark blue opaque cap printed with '238' in white ink and a dark blue opaque body and are supplied as: NDC 68382-238-14 in bottle of 60 capsules NDC 68382-238-05 in bottle of 500 capsules NDC 68382-238-80 in cartons of 80 capsules (8 x 10 unit-dose) Ziprasidone hydrochloride capsules, 60 mg are white to slightly pink granular powder filled in size '2' hard gelatin capsules having a white opaque cap printed with '239' in black ink and a white opaque body and are supplied as: NDC 68382-239-14 in bottle of 60 capsules NDC 68382-239-05 in bottle of 500 capsules NDC 68382-239-80 in cartons of 80 capsules (8 x 10 unit-dose) Ziprasidone hydrochloride capsules, 80 mg are white to slightly pink granular powder filled in size '1' hard gelatin capsules having a dark blue opaque cap printed with '240' in white ink and a light blue opaque body and are supplied as: NDC 68382-240-14 in bottle of 60 capsules NDC 68382-240-05 in bottle of 500 capsules NDC 68382-240-80 in cartons of 80 capsules (8 x 10 unit-dose) Ziprasidone hydrochloride capsules should be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].


More pills like CAPSULE 238

Related Pills

ziprasidone 80 MG Oral Capsule

Zydus Pharmaceuticals (USA) Inc.

ziprasidone 60 MG Oral Capsule

Zydus Pharmaceuticals (USA) Inc.

ziprasidone 20 MG Oral Capsule

Zydus Pharmaceuticals (USA) Inc.

Amlodipine 5 mg

Exelan Pharmaceuticals, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site